Peter Brooks

Q: What Schools Are Affiliated With Peter Brooks

Peter Brooks is affiliated with the following schools: University of Queensland, University of New South Wales, Stanford University, University of the Sunshine Coast

Peter Brooks's AcademicInfluence.com Rankings

Peter Brooks

Computer Science

#4978

World Rank

#5258

Historical Rank

Machine Learning

#1154

World Rank

#1174

Historical Rank

Artificial Intelligence

#1384

World Rank

#1412

Historical Rank

Database

#2145

World Rank

#2256

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Peter Brooks's Degrees

PhD Computer Science Stanford University

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026

Why Is Peter Brooks Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter Brooks's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (9252)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (8152)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (5270)
The global burden of low back pain: estimates from the Global Burden of Disease 2010 study (2014) (2170)
A systematic review of the global prevalence of low back pain. (2012) (2156)
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. (2012) (1485)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1241)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials (2011) (1163)
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012) (1159)
The Epidemiology of low back pain. (2010) (1063)
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. (1997) (730)
The OMERACT filter for Outcome Measures in Rheumatology. (1998) (669)
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. (2014) (637)
Nonsteroidal antiinflammatory drugs--differences and similarities. (1991) (614)
The global burden of neck pain: estimates from the Global Burden of Disease 2010 study (2014) (568)
The burden of musculoskeletal disease—a global perspective (2006) (559)
A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery. (2001) (408)
The burden of musculoskeletal conditions at the start of the new millennium (2003) (362)
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. (2011) (354)
Measuring the global burden of low back pain. (2010) (353)
Minimal clinically important differences: review of methods. (2001) (340)
Placing the global burden of low back pain in context. (2013) (317)
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. (2000) (293)
Does colchicine work? The results of the first controlled study in acute gout. (1987) (273)
Clinical Pharmacokinetics of the Salicylates (1985) (257)
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. (1999) (217)
Minimal disease activity for rheumatoid arthritis: a preliminary definition. (2005) (203)
Reflecting on the global burden of musculoskeletal conditions: lessons learnt from the Global Burden of Disease 2010 Study and the next steps forward (2014) (201)
Nonsteroidal antiinflammatory drugs--differences and similarities. (1991) (182)
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. (2004) (167)
Characterization of carbonaceous combustion residues. I. Morphological, elemental and spectroscopic features. (2003) (165)
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. (2002) (158)
Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease. (2000) (156)
Evidence-based Management of Acute Musculoskeletal Pain (2003) (155)
Patient self-efficacy and health locus of control: relationships with health status and arthritis-related expenditure. (2006) (147)
The global burden of musculoskeletal conditions for 2010: an overview of methods (2014) (145)
n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis (1994) (140)
Therapeutic Manuka Honey: No Longer So Alternative (2016) (138)
Structural requirements for drug binding to site II on human serum albumin. (1983) (137)
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. (2007) (133)
A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. (2004) (116)
Type IIA Secretory Phospholipase A2 Up-Regulates Cyclooxygenase-2 and Amplifies Cytokine-Mediated Prostaglandin Production in Human Rheumatoid Synoviocytes1 (2000) (112)
Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. (1993) (112)
Living with rheumatoid arthritis: expenditures, health status, and social impact on patients (2002) (106)
HAEMOPOIETIC STEM CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES (1997) (103)
Characterization of carbonaceous combustion residues: II. Nonpolar organic compounds. (2003) (100)
Use and benefits of nonsteroidal anti-inflammatory drugs. (1998) (99)
Evidence-Based Rheumatology (2003) (98)
Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. (1992) (96)
Two knees or not two knees? Patient costs and outcomes following bilateral and unilateral total knee joint replacement surgery for OA. (2004) (95)
A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. (1999) (92)
Quantification of leukotriene B4 in synovial fluid by gas chromatography/tandem mass spectrometry. (1988) (88)
Standards of care for acute and chronic musculoskeletal pain: the Bone and Joint Decade (2000-2010). (2008) (87)
Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. (1985) (87)
An analysis of the relationship between psychological morbidity and disease activity in rheumatoid arthritis. (1988) (85)
Interventions for treating psoriatic arthritis (2000) (85)
The Occurrence of Bioactive Micromonosporae in Aquatic Habitats of the Sunshine Coast in Australia (2008) (83)
A controlled evaluation of arthritis education. (1989) (83)
Sulfasalazine in early rheumatoid arthritis (1992) (82)
How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0 (2014) (81)
Living with osteoarthritis: patient expenditures, health status, and social impact. (2001) (80)
Standardizing Assessment and Reporting of Adverse Effects in Rheumatology Clinical Trials II: the Rheumatology Common Toxicity Criteria v.2.0 (2007) (75)
Determinants of disability in rheumatoid arthritis. (1988) (75)
A 5-year follow-up of a controlled trial of an arthritis education programme. (1995) (75)
Cost of joint replacement surgery for osteoarthritis: the patients' perspective. (2002) (73)
Anti-staphylococcal activity of C-methyl flavanones from propolis of Australian stingless bees (Tetragonula carbonaria) and fruit resins of Corymbia torelliana (Myrtaceae). (2014) (73)
Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. (1998) (72)
Non‐steroidal anti‐inflammatory drug toxicity in the upper gastrointestinal tract (2000) (70)
Use of complementary medicines for osteoarthritis—a prospective study (2004) (70)
Antirheumatic drugs: a proposed new classification. (1993) (70)
Non‐steroidal anti‐inflammatory drug associated ulcer: Epidemiology, causation and treatment (1991) (69)
Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis. (1989) (68)
Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. (1976) (67)
A critical evaluation of high performance liquid chromatography‐electrospray ionisation‐mass spectrometry and capillary electrophoresis‐ electrospray‐mass spectrometry for the detection and determination of small molecules of significance in clinical and forensic science (2004) (67)
Antirheumatic drugs in pregnancy and lactation. (1990) (67)
Psoriatic arthritis: a quantitative overview of therapeutic options. The Psoriatic Arthritis Meta-Analysis Study Group. (1997) (65)
Cost-Effectiveness of Interventions for Musculoskeletal Conditions (2006) (65)
Long‐term outcome of autoimmune disease following allogeneic bone marrow transplantation (1998) (63)
Fuel characterisation, engine performance, combustion and exhaust emissions with a new renewable Licella biofuel (2015) (62)
Plasma aspirin esterases in normal individuals, patients with alcoholic liver disease and rheumatoid arthritis: characterization and the importance of the enzymic components (1980) (61)
Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium (1998) (61)
Alterations in prednisolone disposition as a result of time of administration, gender and dose. (1984) (60)
Determinants of willingness to pay for hip and knee joint replacement surgery for osteoarthritis. (2000) (60)
Cerumen of Australian stingless bees (Tetragonula carbonaria): gas chromatography-mass spectrometry fingerprints and potential anti-inflammatory properties (2011) (60)
The Antibacterial Activity of Australian Leptospermum Honey Correlates with Methylglyoxal Levels (2016) (59)
Protein Binding of some Non-steroidal Anti-inflammatory Drugs in Rheumatoid Arthritis (1982) (57)
Articular manifestations of acromegaly. (1988) (56)
Development of the effective musculoskeletal consumer scale. (2007) (56)
Updating the OMERACT Filter: Implications for Patient-reported Outcomes (2014) (55)
Selection of patients for inpatient rehabilitation or direct home discharge following total joint replacement surgery: a comparison of health status and out-of-pocket expenditure of patients undergoing hip and knee arthroplasty for osteoarthritis (2005) (54)
Injectable gold compounds: an overview. (1996) (54)
Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals. (1988) (54)
Disease-modifying antirheumatic drugs. (1997) (52)
Interventions for psoriatic arthritis. (2000) (49)
Variations in response to non-steroidal anti-inflammatory drugs. (1987) (49)
Influence of fuel-oxygen content on morphology and nanostructure of soot particles (2019) (48)
Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming 'chondromodulating' activity. (1994) (47)
Indomethacin--aspirin interaction: a clinical appraisal. (1975) (47)
Prevention of musculoskeletal conditions in the developing world. (2008) (46)
Stem cell transplantation for autoimmune diseases (2009) (46)
A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario. (1988) (46)
Identifying Preliminary Domains to Detect and Measure Rheumatoid Arthritis Flares: Report of the OMERACT 10 RA Flare Workshop (2011) (45)
Copper‐salicylate gel for pain relief in osteoarthritis: a randomised controlled trial (1997) (45)
NSAID and osteoarthritis--help or hindrance? (1982) (44)
A convenient new analysis of dihydroxyacetone and methylglyoxal applied to Australian Leptospermum honeys (2012) (44)
Antirheumatic medication during lactation. (1985) (44)
The psychosocial and clinical status of younger women with early rheumatoid arthritis: a longitudinal study with frequent measures. (1994) (43)
Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate. (1986) (43)
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. (1988) (43)
Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis. (1987) (42)
Observations on Drug Prescribing in Rheumatoid Arthritis (1974) (42)
Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients. (1983) (41)
The clinical significance of indomethacin-probenecid interaction. (1974) (40)
Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT) (2016) (40)
The association between external weather conditions and pain and stiffness in women with rheumatoid arthritis. (1997) (40)
Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study. (1976) (40)
A comparative study of the safety and efficacy of dysprosium-165 hydroxide macro-aggregate and yttrium-90 silicate colloid in radiation synovectomy--a multicentre double blind clinical trial. Australian Dysprosium Trial Group. (1994) (39)
Gold therapy in the elderly rheumatoid arthritis patient. (1983) (38)
A Review of its Pharmacological Properties and Therapeutic Efficacy in the Treatment of Rheumatoid Arthritis (1995) (38)
Issues with chronic musculoskeletal pain. (2005) (38)
Comparison of methylprednisolone (1 g i.v.) with prednisolone (1 g orally) in rheumatoid arthritis: a pharmacokinetic and clinical study. (1988) (37)
Allogeneic bone marrow transplantation from a donor with severe active rheumatoid arthritis not resulting in adoptive transfer of disease to recipient (1997) (37)
Etoricoxib for arthritis and pain management (2006) (37)
Rheumatic manifestations of neoplasia. (1992) (36)
Psychological predictors of disease course in rheumatoid arthritis. (1987) (36)
Regional, annual, and individual variations in the dihydroxyacetone content of the nectar of ma̅nuka (Leptospermum scoparium) in New Zealand. (2014) (36)
A survey of outcome measurement procedures in routine rheumatology outpatient practice in Australia. (1999) (36)
Metabolism of salicylate during chronic aspirin therapy. (1980) (36)
Antirheumatic medication in pregnancy. (1985) (36)
Effects of roasting on kernel peroxide value, free fatty acid, fatty acid composition and crude protein content (2017) (36)
Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease (2004) (34)
Monosodium urate crystals in asymptomatic knee joints. (1982) (34)
A survey of current prescribing practices of anti‐inflammatory and urate‐lowering drugs in gouty arthritis in New South Wales and Queensland (1989) (33)
Lipid-coated polymeric nanoparticles for cancer drug delivery (2018) (33)
Biological effects of nonsteroidal anti-inflammatory drugs. (1975) (33)
Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study. (1990) (32)
Topophysis in Corymbia torelliana × C. citriodora seedlings: adventitious rooting capacity, stem anatomy, and auxin and abscisic acid concentrations (2015) (32)
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. II. Effects on immune and inflammatory indices in peripheral blood. (1988) (32)
Investigation of the effects of the fatty acid profile on fuel properties using a multi-criteria decision analysis (2015) (32)
Report of the OMERACT task force on economic evaluation. Outcome Measures in Rheumatology. (1999) (30)
Clinico-Pharmacological Studies on Ketoprofen (‘Orudis’) (1975) (30)
Retardation of articular cartilage degradation by glycosaminoglycan polysulfate, pentosan polysulfate, and DH-40J in the rat air pouch model. (1989) (30)
Nutritional quality of almond, canarium, cashew and pistachio and their oil photooxidative stability (2019) (29)
Alterations in prednisolone disposition as a result of oral contraceptive use and dose. (1984) (28)
Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis (2008) (28)
Attributes and skills of an effective musculoskeletal consumer. (2005) (28)
Articular chondrocalcinosis in a hospital population: an Australian experience. (1984) (28)
Stem cells in the aetiopathogenesis and therapy of rheumatic disease. (2001) (27)
Early detection of aortic dilatation in ankylosing spondylitis using echocardiography. (1982) (27)
Chemical composition and antimicrobial activity of honeybee (Apis mellifera ligustica) propolis from subtropical eastern Australia (2015) (27)
Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine. (1995) (27)
A first step to assess harm and benefit in clinical trials in one scale. (2010) (26)
Phloroglucinols from Anti‐Microbial Deposit‐Resins of Australian Stingless Bees (Tetragonula carbonaria) (2015) (26)
Perception--a problem in the grading of sacro-iliac joint radiographs. (1984) (26)
In vitro antibacterial phenolic extracts from "sugarbag" pot-honeys of Australian stingless bees (Tetragonula carbonaria). (2014) (26)
Effect of Australian Propolis from Stingless Bees (Tetragonula carbonaria) on Pre-Contracted Human and Porcine Isolated Arteries (2013) (25)
The disposition of biphenylacetic acid following topical application (2004) (25)
Prospective audit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes (1989) (25)
Dereplication of phytochemicals in plants by LC-ESI-MS and ESI-MSn (2012) (25)
Methylprednisolone infusion therapy in rheumatoid arthritis patients. The effect on synovial fluid lymphocyte subsets and inflammatory indices. (1986) (24)
Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats. (1985) (24)
Preventing acute gout when starting allopurinol therapy (1993) (24)
Molecular Characterisation of Colour Formation in the Prawn Fenneropenaeus merguiensis (2013) (24)
Stem cell transplantation in autoimmune disease. (1995) (24)
Analysis of D-penicillamine in plasma by fluorescence derivatisation with N-[p-(2-benzoxazolyl)-phenyl] maleimide and high-performance liquid chromatography. (1983) (23)
Comparative effectiveness of 5 analgesics in patients with rheumatoid arthritis and osteoarthritis. (1982) (23)
Can occupational therapy intervention play a part in maintaining independence and quality of life in older people? A randomised controlled trial (1996) (23)
Hematopoietic stem cell transplantation in rheumatic diseases. (1999) (23)
Histamine Receptors in the Synovial Microcirculation (1975) (23)
Lymphocyte subsets and inflammatory indices in synovial fluid and blood of patients with rheumatoid arthritis. (1984) (23)
Current practice in antimalarial drug prescribing in rheumatoid arthritis. (1986) (23)
Considerations for the safe prescribing and use of COX‐2‐specific inhibitors (2002) (23)
N-3 PUFAs Protect against Aortic Inflammation and Oxidative Stress in Angiotensin II-Infused Apolipoprotein E-/- Mice (2014) (22)
A controlled evaluation of diagnostic criteria in the development of a rheumatology expert system. (1989) (22)
Tophaceous gout of the axial skeleton. (1988) (22)
Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis. (1975) (22)
Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets (2017) (22)
Close temporal and anatomic relationship between multicentric reticulohistiocytosis and carcinoma of the breast. (1992) (22)
In rural Tibet, the prevalence of lower limb pain, especially knee pain, is high: an observational study. (2010) (22)
Variability in response to NSAIDs. Fact or fiction? (1988) (21)
Association Between Measures of Fatigue and Health-Related Quality of Life in Rheumatoid Arthritis and Osteoarthritis (2008) (21)
Experimental Analysis of the Morphology and Nanostructure of Soot Particles for Butanol/Diesel Blends at Different Engine Operating Modes (2019) (21)
The chondroprotective drugs, Arteparon and sodium pentosan polysulphate, increase collagenase activity and inhibit stromelysin activity in vitro. (1992) (21)
Lessons from Exploring Chemical Space and Chemical Diversity of Propolis Components (2020) (21)
Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable? (1999) (21)
A comparison of plasma methylprednisolone concentrations following intra-articular injection in patients with rheumatoid arthritis and osteoarthritis. (1983) (20)
Evaluation of the composition of omega-3 fatty acids in dietary oil supplements. (2010) (20)
Updating the OMERACT Filter: Discrimination and Feasibility (2014) (20)
Nonsteroidal Anti-Inflammatory Drugs (1994) (20)
Quantitation of Dihydroxyacetone in Australian Leptospermum Nectar via High-Performance Liquid Chromatography. (2015) (19)
The chemistry of an unusual seed dispersal mutualism: bees use a complex set of olfactory cues to find their partner (2014) (19)
Biodistribution of64Cu in inflamed rats following administration of two anti-inflammatory copper complexes (2005) (19)
The effect of frusemide on indomethacin plasma levels. (1974) (19)
Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes. (1991) (19)
Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting (2017) (18)
Is diet important in rheumatoid arthritis? (1991) (18)
Chemical Constituents of Kino Extract from Corymbia torelliana (2014) (18)
Pentosan polysulfate (Cartrophen) prevents the hydrocortisone induced loss of hyaluronic acid and proteoglycans from cartilage of rabbit joints as well as normalizes the keratan sulfate levels in their serum. (1989) (18)
Ranitidine disposition in patients with renal impairment. (1983) (18)
The characterisation of synthetic and natural-product pharmaceuticals by electrospray ionisation-mass spectrometry (ESI-MS) and liquid chromatography (LC)-ESI-MS (2006) (17)
Serum immunoreactive gastrin: specificity for rheumatoid arthritis, bimodality of distribution, and failure of effect of anti-inflammatory drugs. (1976) (17)
Dihydroxyacetone Production in the Nectar of Australian Leptospermum Is Species Dependent. (2018) (17)
Migration of blood and synovial fluid neutrophils obtained from patients with rheumatoid arthritis. (1980) (17)
An investigation of bioactive phytochemicals in the leaves of Melicope vitiflora by electrospray ionisation ion trap mass spectrometry. (2009) (16)
DISEASE MODIFYING ANTIRHEUMATIC DRUGS (1998) (16)
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update. (2005) (16)
Variability in response to nonsteroidal anti-inflammatory analgesics: evidence from controlled clinical therapeutic trial of flurbiprofen in rheumatoid arthritis. (1988) (16)
Osteoarthritis in Older Patients (1995) (16)
Computed tomography of paraspinal musculature in ankylosing spondylitis. (1984) (16)
Hematopoietic stem cell transplantation for autoimmune diseases. (1997) (16)
Current issues of methotrexate and cyclosporine. (1992) (16)
Use of The Global Alliance for Musculoskeletal Health survey module for estimating the population prevalence of musculoskeletal pain: findings from the Solomon Islands (2018) (15)
Crystal‐induced inflammation in the rat subcutaneous air‐pouch (1987) (15)
Tenoxicam compared with diclofenac in patients with ankylosing spondylitis. (1990) (15)
Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis. (1984) (15)
Relationships between Nut Size, Kernel Quality, Nutritional Composition and Levels of Outcrossing in Three Macadamia Cultivars (2020) (15)
Rapid and Reliable HPLC Method for the Simultaneous Determination of Dihydroxyacetone, Methylglyoxal and 5-Hydroxymethylfurfural in Leptospermum Honeys (2016) (15)
The effect of slow-acting anti-rheumatic drugs (SAARDs) and combinations of SAARDs on monokine production in vitro. (1991) (15)
Inhibition of leucotriene B4 synthesis by BW 755c does not reduce polymorphonuclear leucocyte (PMNL) accumulation induced by monosodium urate crystals. (1988) (14)
Omega-3 Fatty Acids Modulate Weibel-Palade Body Degranulation and Actin Cytoskeleton Rearrangement in PMA-Stimulated Human Umbilical Vein Endothelial Cells (2013) (14)
The subcutaneous air pouch model of synovium and the inflammatory response to heat aggregated gammaglobulin (2005) (14)
Combined exposure to pyrene and fluoranthene and their molecular effects on the Sydney rock oyster, Saccostrea glomerata. (2016) (14)
Prospective pilot study of intravenous pulse cyclophosphamide therapy for refractory rheumatoid arthritis (1989) (14)
Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients (2004) (14)
Antibacterial Properties of Flavonoids from Kino of the Eucalypt Tree, Corymbia torelliana (2017) (14)
Immunoreactive gastrin and gestation. (1975) (14)
Hazards of low dose methotrexate. (1995) (14)
Pentosan polysulphate stimulates hyaluronate and DNA synthesis in synovial fibroblasts and partially reduces the suppressive effect of hydrocortisone on fibroblast metabolism (1988) (14)
Rheumatic manifestations of malignancy. (1994) (13)
Problems of Antiarthritic Therapy in the Elderly (1984) (13)
Rebound rise in renin concentrations after cessation of salicylates. (1980) (13)
An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis. (1976) (13)
Isolation and propagation of endothelial cells derived from rheumatoid synovial microvasculature. (1989) (13)
Serum uric acid-its relationship to lean body mass sex, plasma urea, intracellular potassium and packed cell volume in a normal population group. (1975) (13)
OMERACT 9 ‒ 9th International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials (2009) (13)
COX‐2 inhibitors (2000) (13)
Piroxicam versus naproxen in the treatment of painful shoulder. (1986) (13)
OMERACT 9 ‒ 9th International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials (2009) (13)
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. III. Effects on immune and inflammatory indices in synovial fluid. (1988) (12)
Chondroprotection--exploring the concept. (1991) (12)
Psychoimmunology and Rheumatoid Arthritis: Concepts and Methodologies (1990) (12)
Rheumatoid arthritis: Aetiology and clinical features. (2002) (12)
PHARMACOKINETICS OF SUSTAINED RELEASE ASPIRIN (1978) (12)
Use of kinetic data to model potential antioxidant activity: Radical scavenging capacity of Australian Eucalyptus honeys. (2020) (11)
Non-steroidal Anti-Inflammatory Drugs Basis for Variability in Response (1985) (11)
Challenges and progress in adverse event ascertainment and reporting in clinical trials. (2005) (11)
7 Pharmacotherapy and osteoarthritis (1997) (11)
Anti-rheumatic drug-prescribing behaviour of Australasian rheumatologists 1984-1994. (1997) (11)
Azapropazone - its place in the management of rheumatoid conditions. (1976) (11)
Non‐steroidal anti‐inflammatory drug induced upper gastrointestinal haemorrhage and bleeding (1992) (11)
Mechanism of action of non-steroidal anti-rheumatic drugs. (1988) (11)
A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. (1982) (10)
Role of immune complexes in hypertrophic osteoarthropathy and nonmetastatic polyarthritis. (1981) (10)
Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology. (1999) (10)
OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions (2019) (10)
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group (2017) (10)
The quantitation of hydroxymethylfurfural in Australian Leptospermum honeys (2013) (10)
Assessment of the Role of Local Strawberry Rhizosphere—Associated Streptomycetes on the Bacterially—Induced Growth and Botrytis cinerea Infection Resistance of the Fruit (2010) (10)
A PHARMACOLOGICAL AND HISTOLOGICAL EXAMINATION OF THE MICROCIRCULATION OF THE RAT SUBCUTANEOUS AIR‐POUCH: MICROCIRCULATION OF THE RAT AIR‐POUCH (1987) (10)
Oncogenic hypophosphatemic osteomalacia associated with a giant cell tumour of a tendon sheath. (1987) (10)
A reappraisal of co‐trimoxazole (1988) (10)
THE BONE AND JOINT DECADE – 2000–10 (2002) (10)
Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine. (1984) (10)
The assessment of disability and handicap in musculoskeletal disease. (1997) (9)
Bimodal effect of gold on IL-1 production by blood monocytes. (1989) (9)
Outcomes after osteoarthritis hip or knee replacement surgery. A prospective cohort study comparing patients' quality of life before and after surgery with age-related population norms (1999) (9)
Essential oils from Leptospermums of the Sunshine Coast and Northern Rivers Regions (2012) (9)
An artificial neutral network (ANN) model for predicting biodiesel kinetic viscosity as a function of temperature and chemical compositions (2013) (9)
How safe are anti-rheumatic drugs? A study of possible iatrogenic deaths in patients with rheumatoid arthritis. (1975) (9)
A Nycodenz gradient method for the purification of neutrophils from the peripheral blood of rats. (1991) (9)
Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine. (1996) (9)
12. Toxicity of antirheumatic drugs (1997) (9)
Introduction - OMERACT IV: Fourth International Consensus Conference on Outcome Measures in Rheumatology (1999) (9)
Fragmentation‐free LC‐MS can identify hundreds of proteins (2011) (9)
Pollen Paternity Can Affect Kernel Size and Nutritional Composition of Self-Incompatible and New Self-Compatible Almond Cultivars (2021) (9)
Salicylates and creatinine clearance re-evaluated. (1978) (9)
Outcome measures in rheumatoid arthritis: the OMERACT process (2007) (9)
How to Ascertain Drug Safety in the Context of Benefit. Controversies and Concerns (2009) (9)
n-3 PUFAs improve erythrocyte fatty acid profile in patients with small AAA: a randomized controlled trial[S] (2019) (9)
Musculoskeletal medicine: the challenge of the Bone and Joint Decade (2004) (9)
Osteoarthritis in older patients. Optimum treatment. (1995) (9)
Prediction of organ system toxicity with antirheumatic drug therapy (1991) (9)
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach. (2021) (8)
The Australian general practice morbidity and prescribing survey, 1969 to 1974. 5. Aspects of morbidity: diseases of the musculoskeletal system. (1976) (8)
Protein binding of GP53,633: a basic non-steroidal anti-inflammatory drug. (1982) (8)
Salivary antipyrine half-life: a useful measure of hepatic drug metabolism. (1976) (8)
Prediction of the clinical efficacy of and intolerance to antirheumatic drug therapy (1991) (8)
The ILAR lecture - The burden of rheumatic diseases; The global perspective (2005) (8)
Are rheumatoid arthritis patients more willing to accept non-steroidal anti-inflammatory drug treatment risks than osteoarthritis patients? (1997) (8)
How to manage musculoskeletal conditions. (2008) (8)
Synthesis of 2H8‐leukotriene B4 (1987) (8)
Streptophage-mediated control of off-flavour taint producing streptomycetes isolated from barramundi ponds (2017) (8)
Assessment of nonsteroidal anti-inflammatory drug combinations by the polyurethane sponge implantation model in the rat. (1983) (8)
Influence of prednisolone and methotrexate on cellular and biochemical aspects of acute and chronic inflammation studied in subcutaneously implanted sponges in rats. (1986) (8)
Natural products isolated from Tetragonula carbonaria cerumen modulate free radical-scavenging and 5-lipoxygenase activities in vitro (2017) (7)
Pharmacotherapy and osteoarthritis. (1997) (7)
Peripheral blood stem cell transplantation for rheumatoid arthritis--Australian experience. (2001) (7)
Investigation of antibacterial phytochemicals in the bark and leaves of Ficus coronata by high‐performance liquid chromatography‐electrospray ionization–ion trap mass spectrometry (HPLC‐ESI‐MSn) and ESI‐MSn (2012) (7)
Combined pyrolysis and sulphided NiMo/Al2O3 catalysed hydroprocessing in a multistage strategy for the production of biofuels from milk processing waste (2021) (7)
Combination chemotherapy in rheumatoid arthritis. (1991) (7)
Disease-modifying agents and immunosuppressive drugs in the elderly. (1986) (7)
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion (2019) (7)
Management of acute musculoskeletal pain (2005) (7)
The cycling of combination antirheumatic drug therapy in rheumatoid arthritis. (1990) (7)
Gold compounds in rheumatic diseases — 2 (1984) (7)
Salivary salicylate secretion and flow rate. (1978) (7)
Nonsteroidal anti-inflammatory drugs. Differential use in older patients. (1994) (7)
ACADEMIC MEDICINE IN CRISIS (1988) (7)
Observations from the OMERACT Drug Safety Summit, May 2008 (2009) (7)
Osteoarthritis antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent dependent outcome measures (1997) (7)
Quantitation of biphenylacetic acid in plasma and synovial fluid by gas chromatography-mass spectrometry-mass spectrometry. (1987) (6)
A destructive discovertebral lesion: Septic discitis, ankylosing spondylitis, or rheumatoid arthritis ? (1989) (6)
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials (2019) (6)
Acute shoulder pain (2004) (6)
Effect of Oxygenated Functional Groups in Essential Oils on Diesel Engine Performance, Emissions, and Combustion Characteristics (2019) (6)
Clinical trials in osteoarthritis. (1996) (6)
The use of antirheumatic medication during pregnancy and in the puerperium. (1989) (6)
[Clinical study on a new acetylsalicylic acid/paracetamol preparation with gastric acid resistant coating (Safapryn), and on two various phenylbutazone dosages in patients with primary chronic polyarthritis as based on a new evaluation method]. (1975) (5)
Study of opening medicine bottles in patients with rheumatoid arthritis (1976) (5)
Fuel feedstock determines biodiesel exhaust toxicity in a human airway epithelial cell exposure model. (2021) (5)
Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency. (1986) (5)
d-Penicillamine metabolism in anin-vivo model of inflamed synovium (2005) (5)
The effect of tiaprofenic acid on blood pressure control in treated hypertensive patients. (1985) (5)
New Uses for Allopurinol (1994) (5)
The metabolism leukotriene B4 in synovial fluid and whole human blood (1987) (5)
Guidelines for use of antirheumatic drugs. (1994) (5)
In Vitro Antibacterial Phenolic Extracts from “Sugarbag” Pot-Honeys of Australian Stingless Bees (Tetragonula carbonaria) (2015) (5)
An Australian survey of current prescribing practices of methotrexate in rheumatoid arthritis. (1994) (5)
Interactions of anti-rheumatic drugs. (1977) (5)
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials (2019) (5)
A study of the antibacterial activities of selected Australian medicinal plants (2009) (5)
The use of suppressive agents for the treatment of rheumatoid arthritis. (1993) (5)
Naproxen and diflunisal in osteoarthrosis. (1982) (4)
Moderate Dietary Supplementation with Omega-3 Fatty Acids Does Not Impact Plasma Von Willebrand Factor Profile in Mildly Hypertensive Subjects (2015) (4)
BURDEN OF MUSCULOSKELETAL DISEASE (2006) (4)
RSI--regional pain syndrome: the importance of nomenclature. (1989) (4)
Patient-Reported Pain is Central to OMERACT Rheumatology Core Measurement Sets (2006) (4)
Global and Country Specific Burden Of Musculoskeletal Disorders: a Report From The Global Burden Of Diseases Musculoskeletal Expert Group. (2013) (4)
Changes in Plasma Kininogen Levels associated with Rheumatoid Arthritis (1975) (4)
Undergraduate education in rheumatology. (1979) (4)
Principles of management of patients with rheumatic disease (2003) (4)
Vessel-like sprouts may develop from fibroblasts in vitro. (1987) (4)
Interaction between levamisole and aspirin in man. (1979) (4)
The management of osteoarthritis in general practice. (1995) (4)
Characterization of Synthetic and Natural Product Pharmaceuticals by Functional Group Analysis using Electrospray Ionization-Ion Trap Mass Spectrometry: A Mini-Review (2015) (4)
Undergraduate education in rheumatology. (1996) (4)
Changing concepts in the management of epithelial ovarian and cervical cancers (1988) (4)
An evaluation of the role of laboratory investigations in establishing a diagnosis of central nervous system lupus. (1988) (4)
Bone and joint disorders: prevention and control (2004) (4)
Bone marrow transplantation in auto-immune disease. (1995) (4)
A letter from Australia. (1995) (4)
Clinical evaluation of tolmetin. (1974) (4)
Raised plasma kininogen levels in rheumatoid patients—Response to therapy with nonsteroidal anti-inflammatory drugs (1976) (4)
Variability in Response to NSAIDs (1988) (4)
Nonsteroidal anti-inflammatory drug gastropathy--is it preventable? (1992) (4)
Recent advances: Rheumatology (1998) (4)
Adsorption and Leachable Contamination of Flucloxacillin, Cyclosporin and Amiodarone Following Delivery Through an Intravenous Administration Set (2018) (3)
DC-ART: decreased inflammatory synovitis. (1994) (3)
Rheumatology training for general practice. (1999) (3)
Influence of Rat Strain and Arthritogen on Actions of Gold Drugs in Adjuvant-Induced Polyarthritis (1984) (3)
Psychosocial measures. (1997) (3)
Proceedings: Ups and downs of indomethacin bioavailability. (1975) (3)
OMERACT 10 — International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials (2011) (3)
CALCIFIC TENDINITIS AT MULTIPLE SITES (1981) (3)
Connective tissue and bone disorders (2000) (3)
Ambivalent effects of anti-arthritic gold on experimental polyarthritis in rats (1982) (3)
Toxicity of antirheumatic drugs. Toxicity Workgroup Leaders. (1995) (3)
Combination therapy in rheumatoid arthritis. (1990) (3)
Temporal arteritis presenting as a symmetrical peripheral polyarthritis. (1983) (3)
Total patient management in rheumatoid arthritis (1983) (3)
Application of an enzyme-linked immunosorbent-inhibition assay to quantitate the release of KS peptides into fluids of the rat subcutaneous air-pouch model and the effects of chondroprotective drugs on the release process (2004) (3)
A Performance Evaluation of Vis/NIR Hyperspectral Imaging to Predict Curcumin Concentration in Fresh Turmeric Rhizomes (2021) (3)
Tropical rheumatology: challenge of the future. (1997) (3)
Clinical evaluation of niflumic acid (Squibb) in rheumatoid arthritis. (1974) (3)
Musculoskeletal disability, chronic disease and labour force participation in Australia (2004) (3)
Recent Developments for Optimal End-Points in Rheumatoid Arthritis Clinical Studies (2000) (3)
Does over a decade of remission from rheumatoid arthritis (RA) after bone marrow transplantation (BMT) represent a cure? Long term follow up of two Australian cases (1996) (2)
Rheumatology manpower in Australia. (1991) (2)
Interactive conference voting. The OMERACT II Committee. Outcome Measures in Rheumatoid Arthritis Clinical Trial Conference. (1995) (2)
Letter: Penicillamine and creaking joints. (1974) (2)
Proceedings: Raised plasma kininogen levels in rheumatoid arthritis. Response to indomethacin and relationship to clinical indices. (1975) (2)
Response to: ‘Overweight/obesity and vitamin D deficiency contribute to the global burden of low back pain’ by Professor Grant (2014) (2)
OMERACT: An Ongoing Evidence‐Based Initiative to Improve the Quality of Outcome Measures in Rheumatology (2009) (2)
Progress Towards Optimal Trial End-Points in Rheumatoid Arthritis (2012) (2)
Expenditure, outcomes and satisfaction 8 years after hip and knee replacement (2005) (2)
Protective Effect of Enprostil against Aspirin-Induced Gastroduodenal Mucosal Comparison with Cimetidine and Sucralfate Injury in Man (1986) (2)
Anti-tumour necrosis factor-a: the dawn of a new era in the treatment of rheumatoid arthritis (2006) (2)
Controversies in the treatment of osteosarcoma (1988) (2)
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamine. (1993) (2)
Callus culture as a new approach for the production of high added value compounds in Ilex paraguariensis: genotype influence, medium optimization and compounds identification. (2020) (2)
Chondroprotection: myth or reality? (1990) (2)
Floral attraction and flower visitors of a subcanopy, tropical rainforest tree, Fontainea picrosperma (2021) (2)
Asymptomatic osteolysis of ribs and clavicles in progressive systemic sclerosis. (1982) (2)
Evaluation of a single daily dose of naproxen in osteoarthritis. (1982) (2)
n of 1 trials in osteoarthritis: Authors’ reply (1995) (2)
The metabolism of synthetic leukotriene B4 in synovial fluid and whole human blood. (1987) (2)
SIDE EFFECTS FROM SEATONE (1980) (2)
PHARMACOKINETICS OF AN OSMOTICALLY CONTROLLED DELIVERY INDOMETHACIN PREPARATION IN NORMAL VOLUNTEERS (1983) (1)
Protocol for evaluation of nonsteroidal antiinflammatory drugs. (1994) (1)
Principles of managing musculoskeletal conditions. Preface. (2008) (1)
Acute thoracic spinal pain (2004) (1)
COX‐2 inhibitors (2000) (1)
The management of rheumatoid arthritis. (1976) (1)
Comparative analgesic andanti-inflammator y properties of sodium salicylate andacetylsalicylic acid(aspirin) inrheumatoid arthritis (1989) (1)
Cortisol does not inhibit prednisolone clearance. (1985) (1)
Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension (1989) (1)
Protein binding of non-steroidal antiinflammatory drugs in rheumatoid arthritis (1980) (1)
Clinical Effects and Interactions of the Non-Steroidal Anti-Inflammatory Drugs (1980) (1)
Rheumatoid arthritis and generalized vaccinia. (1978) (1)
14 – The introduction of new non-steroidal anti-inflammatory drugs (1985) (1)
Interventions for treating psoriatic arthritis (Review) (2011) (1)
THERMOGRAPHY. AUTHOR'S REPLIES (1991) (1)
Corticosteroids, osteoporosis and the Australian rheumatologist (1999) (1)
Anti-staphylococcal properties of propolis from Australian stingless bees Tetragonula carbonaria (2014) (1)
The effect of isoxicam-aspirin combinations on the polyurethane sponge implantation model in the rat. (1986) (1)
Omega-3 fatty acid supplementation increases plasma resolvin D1 levels, and decreases aortic dissection, in an apoE-/- mouse model of abdominal aortic dissection (2013) (1)
Binding ofhaptoglobin, inter-a-trypsin inhibitor, anda,proteinase inhibitor tosynovial fluid hyaluronate andtheinfluence ofthese proteins on itsdegradation byoxygen derived freeradicals (1988) (1)
Immunosuppressive Drugs and Corticosteroids in the Treatment of Rheumatoid Arthritis (1988) (1)
Antibacterial activity of eucalypt gum (2016) (1)
Sensible prescribing. The treatment of rheumatoid arthritis. (1975) (1)
Quality assessment and chemical diversity of Australian propolis from Apis mellifera bees (2022) (1)
Arthritis: the therapeutic challenge (1992) (1)
Introduction (2019) (1)
Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group. (2021) (1)
Night-time indomethacin in rheumatoid arthritis. (1982) (1)
Copper‐salicylate gel for pain relief in osteoarthritis: In reply (1998) (1)
Drug treatment of rheumatoid arthritis. (1978) (1)
Effects of aspirin, naloxone and placebo (1987) (1)
Public and private hospital total joint replacement surgery: any difference in outcomes? (2007) (1)
Non steroidal anti-inflammatory drugs. Risk factors versus benefits. (1991) (1)
Structure-activity relationships for protein binding of a series of basic non-steroidal anti-inflammatory drugs. (1991) (1)
The Influence of Prednisolone (PRED) and Methotrexate (MTX) on the Cell and Connective Tissue Content of Subcutaneously Implanted Polyurethane Sponges in Rats (1984) (1)
Iatrogenic Death in Patients with Rheumatoid Arthritis (1977) (0)
Topophysis in Corymbia torelliana × C. citriodora seedlings: adventitious rooting capacity, stem anatomy, and auxin and abscisic acid concentrations (2014) (0)
Phenylbutazone dose response data in patients with rheumatoid artritis. (1977) (0)
Protein binding of a new, basic non-steroidal anti-inflammatory drug (NSAID), GP 53,633, and its major metabolite (1981) (0)
Plasma and synovial fluid protein binding of non-steroidal anti-inflammatory drugs (NSAID) in arthritic patients (1982) (0)
Sugar and dihydroxyacetone ratios in floral nectar suggest continuous exudation and reabsorption in Leptospermum polygalifolium Salisb. (2022) (0)
In search of biomarkers for dietary fat intake: are phospholipids in red blood cell (RBC) membranes a possible candidate? (2007) (0)
Australian native stingless bee (Tetragonula carbonaria) cerumen modulates dermal fibroblast proliferation, migration and differentiation in vitro (2015) (0)
a Bioactive Fraction, Isolated From Australian Native Stingless Bee (tetragonula Carbonaria) Cerumen, Modulates Dermal Fibroblast Proliferation, Migration, And Differentiation In Vitro (2015) (0)
Rheumatology (1994) (0)
Anti-inflammatory effects and disposition of S- and R-flurbiprofen in the rat☆ (1990) (0)
Extracts of Australian Native Stingless Bee (Tetragonula Carbonaria) Cerumen Differentially Modulate Dermal Fibroblast and Keratinocyte proliferatin in vitro (2014) (0)
SALIVARYSALICYLATE SECRETIONAND FLOWRATE (1978) (0)
Anti-rheumatic therapy through the ages. (1980) (0)
Anti-Fibrotic Potential of Tomentosenol A, a Constituent of Cerumen from the Australian Native Stingless Bee, Tetragonula carbonaria (2022) (0)
Cardiovascular responsiveness to sympathoexcitatory stress in mild-hypertensive and normotensive participants (2013) (0)
Bioactivity-guided fractionation of Australian native stingless bee (Tetragonula carbonaria) propolis extracts, based on in vitro free radical-scavenging and 5-lipoxygenase activities (2013) (0)
Ilex paraguariensis: the effect of genotypes and growth phase on biomass, secondary metabolism and antioxidant activity of in vitro cultivated calli (2022) (0)
Chemical profiles of honeys originating from different floral sources and geographic locations examined by a combination of three extraction and analysis techniques (2015) (0)
Antimicrobial activity of eucalypt resin (2013) (0)
The remarkable story of Manuka Honey (2015) (0)
Alternatives to non‐steroidal anti‐inflammatory drugs (NSAIDS) (1993) (0)
COX-1 and COX-2 in Human Periodontal Disease States (2003) (0)
Trends in complementary and alternative medicine (CAM) use: A 10 year prospective study among osteoarthritis (OA) and rheumatoid arthritis (RA) patients in Australia (2005) (0)
Rheumatology 85 : proceedings of the XVIth International Congress of Rheumatology, Sydney, 19-25 May 1985 (1985) (0)
Current treatment of osteoarthritis (2006) (0)
Chondroprotective effect of extracts of normal human articular cartilage on matrix degradation in the rat subcutaneous air pouch model of inflammation (1999) (0)
Particulate Separation from the Outlet Gas of Plutonium Pyrochemical Processes (2012) (0)
Rheumatology beyond 2000: wither or whither? (1989) (0)
Can your arthritis patients get to the tablets? A study of medicine bottle opening (1981) (0)
Antimalarial-induced ocular toxicity during the treatment of rheumatoid arthritis (1987) (0)
Quality assessment and chemical diversity of Australian propolis from Apis mellifera bees (2022) (0)
Rheumatology in Australia. (1992) (0)
[Septic arthritis in patients with rheumatoid arthritis. Report of 15 cases]. (1976) (0)
Sensible prescribing. VII. The treatment of osteoarthrosis. (1975) (0)
Protective effects of omega-3 polyunsaturated fatty acids in a mouse model of pre-abdominal aortic aneurysm (2014) (0)
Isolation andpropagation ofendothelial cells derived fromrheumatoid synovial microvasculature (1989) (0)
Managing hyperlipidaemia (1988) (0)
Alterations inprednisolone disposition asaresult oftime ofadministration, gender anddose (1984) (0)
What's New? Rheumatology (1994) (0)
Dr. McFariane and Prof. Brooks Reply (1988) (0)
Update on NSAIDs (1999) (0)
Pharmac . ( 1975 ) , 2 , 437-442 PHENYLBUTAZONE : A CLINICO-PHARMACOLOGICAL STUDY IN RHEUMATOID ARTHRITIS (2006) (0)
Evaluation of an ELISA system for determination of class-specific antibodies to native and denatured DNA in man (1986) (0)
Stem cell transplantation in rheumatic diseases (2003) (0)
Principles of arthritis surgery (2003) (0)
Extracts of Australian native stingless bee (Tetragonula carbonaria) cerumen modulate dermal fibroblast proliferation and myofibroblast differentiation in vitro (2014) (0)
Clinical andlaboratory study (1976) (0)
The bone and joint decade: 2000-2010. (2000) (0)
Double-blind controlled assessment of the effect of intra-articular hydrocortisone and urokinase in rheumatoid arthritis. (1974) (0)
Haemopoietic stem cell transplantation (HSCT) for rheumatoid arthritis (RA) (1996) (0)
Osteoarthritis--investigation and management. (1984) (0)
Nonsteroidal anti-inflammatory drug treatment for arthritis. (1978) (0)
Basis for variability of response to anti-rheumatic drugs. Proceedings of a satellite meeting of the Xth International Congress of Pharmacology. Sydney, Australia, August 20-22, 1987. (1988) (0)
Third world conference on variability in response to anti-rheumatic drugs, Singapore, July 22–24, 1992 (1993) (0)
and tolerance of intraarticular hyaluronan in osteoarthritis of the knee . A double blind , randomized , multicenter , parallel group study of the effectiveness (2004) (0)
Tenidap--a new antiarthritic agent. (1993) (0)
Rheumatology: Rheumatological medicine. (1985) (0)
Differential effects of diclofenac and piroxicam on in vivo and in vitro aspects of inflammation in the rat (1990) (0)
SynoviocytesProduction in Human Rheumatoid Amplifies Cytokine-Mediated Prostaglandin Up-Regulates Cyclooxygenase-2 and 2 Type IIA Secretory Phospholipase A (2000) (0)
NSAIDs - Nonsteriodal anti-inflammatory drugs (2003) (0)
Cortisol doesnotinhibit prednisolone clearance (1985) (0)
Combination therapy in rheumatoid arthritis. (1993) (0)
Variability in Response to Anti-Rheumatic Drugs (1993) (0)
implantation model in the rat . polyurethane sponge combinations by the anti-inflammatory drug Assessment of nonsteroidal (0)
Prednisolone/Phenobarbitone Interaction in Rheumatoid Arthritis (1977) (0)
Corrigendum to "Use of kinetic data to model potential antioxidant activity: Radical scavenging capacity of Australian Eucalyptus honeys" [Food Chem. 342 (2021) 128332]. (2021) (0)
Interventions for psoriatic arthritis. (2000) (0)
The toxicity of nonsteroidal antiinflammatory drugs and antirheumatic drugs: an introduction. (1995) (0)
Psoriatic arthritis: an overview of therapy and toxicity (1997) (0)
Clinical pharmacology of GP53,633—a new non-steroidal anti-inflammatory drug — in patients with rheumatoid arthritis (1984) (0)
Comprar Best Practice and Research Clinical Rheumatology | P. Brooks | 9780702031649 | Elsevier (2008) (0)
Endocrine disorders with rheumatic manifestations. (1989) (0)
The Journal of Rheumatology OMERACT Delphi Survey and Consensus Meeting Shared Decision-making Interventions in Rheumatology : Results from an Toward the Development of a Core Set of Outcome Domains to Assess (2017) (0)
Drug safety module: Summary and recommendations (2001) (0)
Drug prescribing in rheumatic diseases. (1984) (0)
Long term out of pocket expenditure and health outcomes for subjects 8 years post hip and knee replacement (2005) (0)
What are the real direct health care costs of total joint replacement (TJR) in Australia (2003) (0)
Comprar Evidence-Based Rheumatology | Michael J. Gibney | 9780727914460 | Wiley (2009) (0)
INTRODUCING o LVANCOCIN * " ORAL VANCOCIN IS THE DRUG OF CHOICE FOR C DIFFICILE ENTEROCOLITIS . " l NEW VANCOON CAPSULES (2018) (0)
Rheumatic manifestations of neoplasia. (1993) (0)
OMERACT: an international initiative to improve outcome measurement in rheumatology. (2005) (0)
The effect of patients' self-efficacy and locus control on health-related quality of life and expenditure among subjects living with osteoarthritis (OA) and rheumatoid arthritis (RA) (2004) (0)
Ecotrin and Sra Clinical-Trial (1979) (0)
Effect of omega-3 fatty acid supplementation on blood pressure and heart rate variability following sympathoexcitatory stress in mild hypertensive and normotensive subjects (2013) (0)
Non-steroidal anti-inflammatory drugs (2003) (0)
Prof. Brooks Replies (1989) (0)
NSAIDs in inflammatory arthropathies : A guide to selection (1996) (0)
A Scoping Review of Contextual Factors of Patient Decision Aids in Osteoarthritis (2017) (0)
Disease modifying antirheumatic drugs (1999) (0)
Group Development of the Effective Musculoskeletal Consumer Scale (2007) (0)
Long term out of pocket expenditure and health outcomes for subjects living with osteoarthritis (OA) and rheumatoid arthritis (RA) (2004) (0)
Plasma methyl prednisolone concentrations following intra articular injection in patients with rheumatoid arthritis and osteo arthritis (1984) (0)
The role of complementary approaches in the management of musculoskeletal pain (1999) (0)
Tropical rheumatology. Treatment issues. (1995) (0)
25×25 strategy for the burden of non-communicable diseases. (2014) (0)
Methanol is a potent inhibitor of the metabolism of endogenous arachidonic acid by elicited rat peritoneal leukocytes. (1990) (0)
Authors' reply (1995) (0)
Patient expectations of joint replacement surgery and post-operative health status (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter Brooks?

Peter Brooks is affiliated with the following schools:

Peter Brooks's Academic­Influence.com Rankings

Peter Brooks's Degrees

Similar Degrees You Can Earn

Why Is Peter Brooks Influential?

Peter Brooks's Published Works

Published Works

What Schools Are Affiliated With Peter Brooks?

Peter Brooks's AcademicInfluence.com Rankings